Protagonist Therapeutics Inc —— 资产负债表 (NASDAQ:PTGX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 324.47 M347.69 M247.93 M357.95 M744.73 M668.19 M 负债总额 44.86 M47.67 M32.32 M21.27 M69.43 M53.48 M 权益总额 279.61 M300.02 M215.61 M336.68 M675.29 M614.71 M 负债及股东权益总额 324.47 M347.69 M247.93 M357.95 M744.73 M668.19 M 总债务 15.75 M————— 净债务 -290.06 M—————

新闻

J&J raises guidance for 2026 on strong start to the year

Growth vs. Stability: Lilly and J&J's 2026 Investment Face-Off

Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE?

J&J's Pipeline Surge Sets Up Stronger Growth From New Drugs in 2026

J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?

Protagonist Partners With JNJ To Compete With AbbVie's Skyrizi (PTGX)

Protagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's Why

Protagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?

J&J Expands New Drug Portfolio With Icotyde's FDA Approval

Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment Transcript

Protagonist Therapeutics股价触及98.65美元历史新高

Protagonist Therapeutics stock hits all-time high at 98.65 USD